About Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Institute of Allergy and Infectious Diseases (NIAID)
2
Clinical Trials at Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS
During the past decade, Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals
2007-08-01
2009-07-01
Completed
29
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
2011-03-01
2013-04-01
Completed
62
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS"
#1 collaborator was "AIDS Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS
According to Clinical.Site data, the most researched conditions in "Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS" are
"HIV Infections" (2 trials) and "Hepatitis C" (1 trials). Many other conditions were trialed in "Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS" in a lesser frequency.
Clinical Trials Intervention Types at Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS
Most popular intervention types in "Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS" are "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Decavac" (1 trials), "IL-12" (1 trials), "Placebo" (1 trials), "Profectus HIV MAG pDNA vaccine" (1 trials) and "Twinrix" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS
The vast majority of trials in "Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS" are
2 trials for "All" genders.
Clinical Trials Status at Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS
Currently, there are NaN active trials in "Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS, 2 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".